Source:http://linkedlifedata.com/resource/pubmed/id/16443270
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2006-2-13
|
pubmed:abstractText |
The release of the anti-inflammatory agent dexamethasone (DEX) from nanoparticles of poly(lactic-co-glycolic acid) (PLGA) embedded in alginate hydrogel (HG) matrices was investigated. DEX-loaded PLGA nanoparticles were prepared using a solvent evaporation technique and were characterized for size, drug loading, and in-vitro release. The crosslinking density of the HG was studied and correlated with drug release kinetics. The amount of DEX loaded in the nanoparticles was estimated as approximately 13 wt%. The typical particle size ranged from 400 to 600 nm. The in-vitro release of DEX from NPs entrapped in the HG showed that 90% of the drug was released over 2 weeks. The impedance of the NP-loaded HG coatings on microfabricated neural probes was measured and found to be similar to the unmodified and uncoated probes. The in-vivo impedance of chronically implanted electrodes loaded with DEX was maintained at its initial level, while that of the control electrode increased by 3 times after about 2 weeks after implantation until it stabilized at approximately 3 MOmega. This improvement in performance is presumably due to the reduced amount of glial inflammation in the immediate vicinity of the DEX-modified neural probe.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biocompatible Materials,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Implants,
http://linkedlifedata.com/resource/pubmed/chemical/Lactic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Polyglycolic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Polymers,
http://linkedlifedata.com/resource/pubmed/chemical/polylactic acid-polyglycolic acid...
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0142-9612
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3031-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:16443270-Animals,
pubmed-meshheading:16443270-Biocompatible Materials,
pubmed-meshheading:16443270-Brain,
pubmed-meshheading:16443270-Dexamethasone,
pubmed-meshheading:16443270-Diffusion,
pubmed-meshheading:16443270-Drug Carriers,
pubmed-meshheading:16443270-Drug Delivery Systems,
pubmed-meshheading:16443270-Drug Implants,
pubmed-meshheading:16443270-Guinea Pigs,
pubmed-meshheading:16443270-Hydrophobic and Hydrophilic Interactions,
pubmed-meshheading:16443270-Lactic Acid,
pubmed-meshheading:16443270-Materials Testing,
pubmed-meshheading:16443270-Nanostructures,
pubmed-meshheading:16443270-Particle Size,
pubmed-meshheading:16443270-Polyglycolic Acid,
pubmed-meshheading:16443270-Polymers
|
pubmed:year |
2006
|
pubmed:articleTitle |
Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
|
pubmed:affiliation |
Biomedical Engineering, University of Michigan, Michigan 48109-2136, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|